ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03035
0,00%
Bitcoin
103.436,23
-0,66%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Nurexone Biologic Inc (NRX) Börsenkurse

Nurexone Biologic Inc

Nurexone Biologic Inc (NRX)

Noronex Limited
0,61
-0,04
(-6,15%)
Geschlossen 18 Januar 10:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,61
Gebot
0,60
Fragen
0,63
Volumen
29.070
0,61 Tagesbereich 0,65
0,27 52-Wochen-Bereich 1,19
Marktkapitalisierung
29,432M
Handelsende
0,65
Handelsbeginn
0,65
Letzte Trade
5000
@
0.61
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
53.717
Ausgegebene Aktien
48.249.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-8,09
Gewinn pro Aktie (EPS)
-0,08
Erlöse
-
Nettogewinn
-3,64M

Über Nurexone Biologic Inc

Sektor
Miscellaneous Metal Ores,nec
Branche
Pharmaceutical Preparations
Website
www.nurexone.com
Hauptsitz
Toronto, Ontario, Can
Gegründet
2011
Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker NRX. The last closing price for Nurexone Biologic was $0,65. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0,27 to $ 1,19.

Nurexone Biologic currently has 48.249.000 shares in issue. The market capitalisation of Nurexone Biologic is $31,36 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -8.09.

NRX Neueste Nachrichten

Weitere Nachrichten

NurExone Biologic Secures Master Cell Bank

TORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a developer of exosome-based...

08 Januar 2025
GlobeNewswire Inc.

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

06 Dezember 2024
GlobeNewswire Inc.

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

27 November 2024
GlobeNewswire Inc.

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

13 November 2024
GlobeNewswire Inc.

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

01 November 2024
GlobeNewswire Inc.

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

TORONTO and HAIFA, Israel, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

23 Oktober 2024
GlobeNewswire Inc.

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

26 September 2024
GlobeNewswire Inc.

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

12 September 2024
GlobeNewswire Inc.

NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study

TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce compelling...

06 September 2024
GlobeNewswire Inc.

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

28 August 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.04-6.153846153850.650.690.61236890.66648337CS
4-0.13-17.56756756760.740.740.6356640.6593725CS
12-0.04-6.153846153850.650.830.59537170.70804908CS
26-0.06-8.95522388060.670.830.52409700.67221128CS
520.33117.8571428570.281.190.27814970.73368682CS
156-0.19-23.750.81.190.1346840.69813397CS
260-0.19-23.750.81.190.1346840.69813397CS

NRX - Frequently Asked Questions (FAQ)

What is the current Nurexone Biologic share price?
The current share price of Nurexone Biologic is $ 0,61
How many Nurexone Biologic shares are in issue?
Nurexone Biologic has 48.249.000 shares in issue
What is the market cap of Nurexone Biologic?
The market capitalisation of Nurexone Biologic is CAD 31,36M
What is the 1 year trading range for Nurexone Biologic share price?
Nurexone Biologic has traded in the range of $ 0,27 to $ 1,19 during the past year
What is the PE ratio of Nurexone Biologic?
The price to earnings ratio of Nurexone Biologic is -8,09
What is the reporting currency for Nurexone Biologic?
Nurexone Biologic reports financial results in USD
What is the latest annual profit for Nurexone Biologic?
The latest annual profit of Nurexone Biologic is USD -3,64M
What is the registered address of Nurexone Biologic?
The registered address for Nurexone Biologic is SUITE 1600, 1 FIRST CANADIAN PLACE, 100 KING STREET, TORONTO, ONTARIO, M5X 1G5
What is the Nurexone Biologic website address?
The website address for Nurexone Biologic is www.nurexone.com
Which industry sector does Nurexone Biologic operate in?
Nurexone Biologic operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AHRAmarc Resources Ltd
$ 0,72
(171,70%)
4,17M
OEG.HONEnergy Inc
$ 0,035
(133,33%)
14,66k
FYLFinlay Minerals Ltd
$ 0,045
(125,00%)
4,86M
CPICarlton Precious Inc
$ 0,16
(113,33%)
1.000
MVYMoovly Media Inc
$ 0,01
(100,00%)
1,5M
GAR.HGreen Arrow Resources Inc
$ 0,015
(-66,67%)
1,96k
CANDCandelaria Mining Corp
$ 0,005
(-50,00%)
553,7k
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
79,65k
AZC.PA2ZCryptocap Inc
$ 0,045
(-50,00%)
33k
BYM.HBaymount Incorporated
$ 0,005
(-50,00%)
5k
FYLFinlay Minerals Ltd
$ 0,045
(125,00%)
4,86M
AGMRSilver Mountain Resources Inc
$ 0,05
(-9,09%)
4,23M
AHRAmarc Resources Ltd
$ 0,72
(171,70%)
4,17M
TDGTDG Gold Corp
$ 0,245
(75,00%)
4,08M
MATEBlockmate Ventures Inc
$ 0,33
(0,00%)
3,99M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
NRX
Nurexone Biologic
DOWI
P1DOW
DJ AsiaPacific
NYSE
CULP
Culp
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten